The Claim
In obese women aged 20–45, a slow weight loss intervention (15–20% caloric deficit over 15 weeks) produces a 39.59% greater reduction in plasma interleukin-1 (IL-1) and a 62.28% greater reduction in high-sensitivity C-reactive protein (hs-CRP) compared to a rapid weight loss intervention (30–35% caloric deficit over 12 weeks), indicating that the rate of weight loss influences the magnitude of systemic inflammation reduction.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese women between 20 and 45 years old, losing weight slowly over 15 weeks with a moderate calorie reduction leads to a larger decrease in two markers of systemic inflammation—interleukin-1 and high-sensitivity C-reactive protein—than losing weight quickly over 12 weeks with a larger calorie reduction.
See the scientific wording
In obese women aged 20–45, slow weight loss (15–20% caloric deficit over 15 weeks) results in a 39.59% greater reduction in plasma interleukin-1 (IL-1) and a 62.28% greater reduction in high-sensitivity C-reactive protein (hs-CRP) compared to rapid weight loss (30–35% caloric deficit over 12 weeks), suggesting that the rate of weight loss influences the magnitude of systemic inflammation reduction.
What the research says
1 studyThis study found that when obese women lose weight slowly over 15 weeks, their body inflammation drops more than when they lose weight quickly over 12 weeks — even if they lose the same total amount of weight.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.